Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
BLUEALLELE CORPORATION currently manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 3 distinct examiners and 3 distinct art units. This distribution indicates that the company's current workload is spread across 3 different administrative segments of the patent office.
The busiest examiner for the company is POPA, ILEANA, who is responsible for 1 busiest examiner pending office action. This 1 action represents 1 of the 3 pending office actions identified in the portfolio. With 3 distinct examiners involved, the prosecution is distributed across multiple individuals, which may lead to varying review outcomes across the 3 art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POPA, ILEANA | 1 | 21.4% | +15.1% |
| PARISI, JESSICA DANIELLE | 1 | 75.8% | +32.3% |
| HASAN, KHALEDA B | 1 | 59.4% | +49.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17273724 | MATERIALS AND METHODS FOR THE CORRECTION OF RETINITIS PIGMENTOSA | POPA, ILEANA | 34d |
| 16670162 | METHODS FOR COMPARING EFFICACY OF DONOR MOLECULES | PARISI, JESSICA DANIELLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17273724 | MATERIALS AND METHODS FOR THE CORRECTION OF RETINITIS PIGMENTOSA | POPA, ILEANA | 34d |
| 16670162 | METHODS FOR COMPARING EFFICACY OF DONOR MOLECULES | PARISI, JESSICA DANIELLE | — |
| 16547019 | METHODS FOR DELIVERING GENE EDITING REAGENTS TO CELLS WITHIN ORGANS | HASAN, KHALEDA B | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| 1684 | 1 |
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17273724 | MATERIALS AND METHODS FOR THE CORRECTION OF RETINITIS PIGMENTOSA | POPA, ILEANA | 1633 | §103 | Non-Final OA | 34d | Pending | Mar 04, 2021 |
| 16670162 | METHODS FOR COMPARING EFFICACY OF DONOR MOLECULES | PARISI, JESSICA DANIELLE | 1684 | §102§103§112 | Non-Final OA | — | Pending | Oct 31, 2019 |
| 16547019 | METHODS FOR DELIVERING GENE EDITING REAGENTS TO CELLS WITHIN ORGANS | HASAN, KHALEDA B | 1636 | §103 | Final Rejection | — | Pending | Aug 21, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial